/ /

Cheryl Guttman Krader
Perioperative surgical home model reduces LOS
The perioperative surgical home is a promising model for delivering high-quality, cost-effective care for patients undergoing inpatient urologic procedures, according to the experience of urologists from Loma Linda University, Loma Linda, CA.
Ureteroscopy may adversely affect erectile function
Results of a retrospective study raise concern that ureteroscopy may adversely affect erectile function.
Cyclosporine shows efficacy in refractory IC patients
Oral cyclosporine can offer a safe and effective treatment option for refractory interstitial, even in patients who have been on chronic narcotic medications and particularly in those with Hunner’s lesions, according to the findings of a study presented by Cleveland Clinic urologists at the 2016 AUA annual meeting in San Diego.
Biochemical recurrence risk high 10 years post-RP
The risk for biochemical recurrence of prostate cancer remains relatively high even 10 years after radical prostatectomy, but it does not appear to be influenced by a positive family history of prostate cancer or a family or personal history of other cancer, according to a study analyzing data from the prospective German Familial Prostate Cancer database.
Urolithiasis mortality rate high in lower income nations
Results of a study analyzing global trends in mortality attributable to urolithiasis show that the rate declined over a recent 20-year period.
PCa: Emotional distress influences treatment decision
Researchers have found that the anxiety men often experience after being diagnosed with prostate cancer could lead to potentially unnecessary treatment options.
Laser-activated PCa therapy promising in phase III study
Researchers evaluate an experimental treatment called vascular-targeted photodynamic therapy in men with localized prostate cancer.
Bone metastases Tx: 12-week dosing interval appears feasible
Results of a 2-year clinical trial support switching to a less frequent administration schedule when using zoledronic acid (Zometa) to prevent skeletal-related events in men with prostate cancer.
Studies reveal drop in PCa treatment, rise in metastatic disease
Findings from two new studies provide insight on the impact of changing recommendations for prostate cancer screening and management.
Delay from biopsy to RP: Who is at risk of recurrence?
The risk of prostate cancer relapse after radical prostatectomy increases with lengthening delay between diagnosis and surgery. The impact, however, is significant only in high-risk patients, and even in those men, there may be a window of up to 12 months during which it may be relatively safe to postpone surgery, reported researchers from Milan, Italy.


View Results